Asc-1 transporter regulation of synaptic activity via the tonic release of -serine in the forebrain

Cerebral Cortex

Volumn 27, Issue 2, 2017, Pages 1573-1587

  Sason, Hagit ^a   Billard, Jean Marie ^b   Smith, Garrick Paul ^c   Safory, Hazem ^a   Neame, Samah ^a   Kaplan, Eitan ^a   Rosenberg, Dina ^a   Zubedat, Salman ^a   Foltyn, Veronika N ^a   Christoffersen, Claus Tornby ^c   Bundgaard, Christoffer ^c   Thomsen, Christian ^c   Avital, Avi ^a,d   Christensen, Kenneth Vielsted ^c   Wolosker, Herman ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

^c H LUNDBECK A S   (Denmark)

^d HAEMEK MEDICAL CENTER   (Israel)

Author keywords

Glycine; Long term potentiation; Neurodegeneration; NMDA receptor; Synaptic plasticity

Indexed keywords

AMINO ACID TRANSPORTER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SLC7A10 PROTEIN, MOUSE;

ANIMAL; EXCITATORY POSTSYNAPTIC POTENTIAL; FOREBRAIN; GENETICS; HUMAN; KNOCKOUT MOUSE; LONG TERM POTENTIATION; METABOLISM; NERVE CELL; NERVE CELL PLASTICITY; PHYSIOLOGY; SYNAPSE; SYNAPTIC TRANSMISSION;

AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; EXCITATORY POSTSYNAPTIC POTENTIALS; HUMANS; LONG-TERM POTENTIATION; MICE, KNOCKOUT; NEURONAL PLASTICITY; NEURONS; PROSENCEPHALON; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 85028490158     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhv350     Document Type: Article

References (40)

1. Anderson WW, Collingridge GL. 2001. The LTP program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J Neurosci Methods. 108:71–83.
2. Balu DT, Takagi S, Puhl MD, Benneyworth MA, Coyle JT. 2014. d-serine and serine racemase are localized to neurons in the adult mouse and human forebrain. Cell Mol Neurobiol. 34:419–435.
3. Baron BM, Siegel BW, Harrison BL, Gross RS, Hawes C, Towers P. 1996. [3H]MDL 105 519, a high-affinity radioligand for the N-methyl-d-aspartate receptor-associated glycine recognition site. J Pharmacol Exp Ther. 279:62–68.
4. Benneyworth MA, Li Y, Basu AC, Bolshakov VY, Coyle JT. 2012. Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons. Cell Mol Neurobiol. 32:613–624.
5. Berger AJ, Dieudonne S, Ascher P. 1998. Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses. J Neurophysiol. 80:3336–3340.
6. Brown JM, Hunihan L, Prack MM, Harden DG, Bronson J, Dzierba CD, Gentles RG, Hendricson A, Krause R, Macor JE, et al. 2014. In vitro characterization of a small molecule inhibitor of the alanine serine cysteine transporter -1 (SLC7A10). J Neurochem. 129:275–283.
7. Ehmsen JT, Ma TM, Sason H, Rosenberg D, Ogo T, Furuya S, Snyder SH, Wolosker H. 2013. d-serine in glia and neurons derives from 3-phosphoglycerate dehydrogenase. J Neurosci. 33:12464–12469.
8. Fukasawa Y, Segawa H, Kim JY, Chairoungdua A, Kim DK, Matsuo H, Cha SH, Endou H, Kanai Y. 2000. Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral d- and l-amino acids. J Biol Chem. 275:9690–9698.
9. Gonzalez-Alvear GM, Werling LL. 1994. Regulation of [3H]dopa-mine release from rat striatal slices by sigma receptor ligands. J Pharmacol Exp Ther. 271:212–219.
10. Hashimoto A, Nishikawa T, Oka T, Takahashi K, Hayashi T. 1992. Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N-tert-butyloxycarbonyl-l-cysteine and o-phthaldialdehyde. J Chromatogr. 582:41–48.
11. Helboe L, Egebjerg J, Moller M, Thomsen C. 2003. Distribution and pharmacology of alanine-serine-cysteine transporter 1 (asc-1) in rodent brain. Eur J Neurosci. 18:2227–2238.
12. Johnson JW, Ascher P. 1987. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 325:529–531.
13. Kartvelishvily E, Shleper M, Balan L, Dumin E, Wolosker H. 2006. Neuron-derived d-serine release provides a novel means to activate N-methyl-d-aspartate receptors. J Biol Chem. 281:14151–14162.
14. Koepsell H. 1998. Organic cation transporters in intestine, kidney, liver, and brain. Annu Rev Physiol. 60:243–266.
15. Le Bail M, Martineau M, Sacchi S, Yatsenko N, Radzishevsky I, Conrod S, Ait Ouares K, Wolosker H, Pollegioni L, Billard J, et al. 2015. Identity of the NMDA receptor coagonist is synapse specific and developmentally regulated in the hippocampus. Proc Natl Acad Sci USA. 112:E204–E213.
16. Li Y, Sacchi S, Pollegioni L, Basu AC, Coyle JT, Bolshakov VY. 2013. Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level. Nat Commun. 4:1760.
17. Lindroth P, Hamberger A, Sandberger M. 1985. Liquid chromatography determination of amino acids after precolumn fluorescent derivatization. In: Boulton AA, Baker GB, Wood JD, editors. Amino acids (neuromethods), 1st ed. Clifton, NJ: The Humana Press, Inc. p. 97–116.
18. Malenka RC. 1994. Synaptic plasticity in the hippocampus: LTP and LTD. Cell. 78:535–538.
19. Martineau M, Shi T, Puyal J, Knolhoff AM, Dulong J, Gasnier B, Klingauf J, Sweedler JV, Jahn R, Mothet JP. 2013. Storage and uptake of d-serine into astrocytic synaptic-like vesicles specify gliotransmission. J Neurosci. 33:3413–3423.
20. Matsui T, Sekiguchi M, Hashimoto A, Tomita U, Nishikawa T, Wada K. 1995. Functional comparison of d-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration. J Neurochem. 65:454–458.
21. Matsuo H, Kanai Y, Tokunaga M, Nakata T, Chairoungdua A, Ishimine H, Tsukada S, Ooigawa H, Nawashiro H, Kobayashi Y, et al. 2004. High affinity d- and l-serine transporter Asc-1: cloning and dendritic localization in the rat cerebral and cerebellar cortices. Neurosci Lett. 358:123–126.
22. McGaugh JL, Roozendaal B. 2009. Drug enhancement of memory consolidation: historical perspective and neurobiological implications. Psychopharmacology (Berl). 202:3–14.
23. Miya K, Inoue R, Takata Y, Abe M, Natsume R, Sakimura K, Hongou K, Miyawaki T, Mori H. 2008. Serine racemase is predominantly localized in neurons in mouse brain. J Comp Neurol. 510:641–654.
24. Mothet JP, Le Bail M, Billard JM. 2015. Time and space profiling of NMDA receptor co-agonist functions. J Neurochem. 135:210–225.
25. Mothet JP, Parent AT, Wolosker H, Brady RO Jr, Linden DJ, Ferris CD, Rogawski MA, Snyder SH. 2000. d-serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proc Natl Acad Sci USA. 97:4926–4931.
26. Nabavi S, Kessels HW, Alfonso S, Aow J, Fox R, Malinow R. 2013. Metabotropic NMDA receptor function is required for NMDA receptor-dependent long-term depression. Proc Natl Acad Sci USA. 110:4027–4032.
27. Papouin T, Ladepeche L, Ruel J, Sacchi S, Labasque M, Hanini M, Groc L, Pollegioni L, Mothet J-P, Oliet SHR. 2012. Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. Cell. 150:633–646.
28. Pineda M, Font M, Bassi MT, Manzoni M, Borsani G, Marigo V, Fernandez E, Rio RM, Purroy J, Zorzano A, et al. 2004. The amino acid transporter asc-1 is not involved in cystinuria. Kidney Int. 66:1453–1464.
29. Radzishevsky I, Wolosker H. 2012. An enzymatic-HPLC assay to monitor endogenous d-serine release from neuronal cultures. Methods Mol Biol. 794:291–297.
30. Ribeiro CS, Reis M, Panizzutti R, de Miranda J, Wolosker H. 2002. Glial transport of the neuromodulator d-serine. Brain Res. 929:202–209.
31. Risgaard R, Ettrup A, Balle T, Dyssegaard A, Hansen HD, Lehel S, Madsen J, Pedersen H, Puschl A, Badolo L, et al. 2013. Radiolabelling and PET brain imaging of the alpha(1)-adrenoceptor antagonist Lu AE43936. Nucl Med Biol. 40:135–140.
32. Rosenberg D, Artoul S, Segal AC, Kolodney G, Radzishevsky I, Dikopoltsev E, Foltyn VN, Inoue R, Mori H, Billard JM, et al. 2013. Neuronal d-serine and glycine release via the Asc-1 transporter regulates NMDA receptor-dependent synaptic activity. J Neurosci. 33:3533–3544.
33. Rosenberg D, Kartvelishvily E, Shleper M, Klinker CM, Bowser MT, Wolosker H. 2010. Neuronal release of d-serine: a physiological pathway controlling extracellular d-serine concentration. Faseb J. 24:2951–2961.
34. Rutter AR, Fradley RL, Garrett EM, Chapman KL, Lawrence JM, Rosahl TW, Patel S. 2007. Evidence from gene knockout studies implicates Asc-1 as the primary transporter mediating d-serine reuptake in the mouse CNS. Eur J Neurosci. 25:1757–1766.
35. Safory H, Neame S, Shulman Y, Zubedat S, Radzishevsky I, Rosenberg D, Sason H, Engelender S, Avital A, Hulsmann S, et al. 2015. The alanine-serine-cysteine-1 (Asc-1) transporter controls glycine levels in the brain and is required for glycinergic inhibitory transmission. EMBO Rep. 16:590–598.
36. Shigetomi E, Jackson-Weaver O, Huckstepp RT, O’Dell TJ, Khakh BS. 2013. TRPA1 channels are regulators of astrocyte basal calcium levels and long-term potentiation via constitutive d-serine release. J Neurosci. 33:10143–10153.
37. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. 2010. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 62:405–496.
38. Volianskis A, France G, Jensen MS, Bortolotto ZA, Jane DE, Collingridge GL. 2015. Long-term potentiation and the role of N-methyl-d-aspartate receptors. Brain Res. 1621:5–16.
39. Wolosker H, Dumin E, Balan L, Foltyn VN. 2008. d-amino acids in the brain: d-serine in neurotransmission and neurodegeneration. FEBS J. 275:3514–3526.
40. Yang Y, Ge W, Chen Y, Zhang Z, Shen W, Wu C, Poo M, Duan S. 2003. Contribution of astrocytes to hippocampal long-term potentiation through release of d-serine. Proc Natl Acad Sci USA. 100:15194–15199.